<DOC>
	<DOCNO>NCT02207114</DOCNO>
	<brief_summary>The propose work provide critical insight potential impact biomarker-based algorithm reduce unnecessary antibiotic use different adult pediatric/neonatal ICU 's . This proposal also assess cost ( saving ) biomarker-based intervention . Overall , result work critical informing future strategy eliminate unnecessary antibiotic use curb continue rise antimicrobial resistance .</brief_summary>
	<brief_title>Using Biomarkers Optimize Antibiotic Strategies Sepsis</brief_title>
	<detailed_description>The goal project reduce unnecessary use antibiotic ICU . The purpose Phase I study identify biomarker , combination biomarkers , provide optimal test characteristic identify adult children/neonates presume sepsis low likelihood bacterial infection . Results Phase I result development biomarker-based algorithm inform need antibiotic use ICU patient . In Phase II , impact biomarker-based algorithm reduce antibiotic use ICU determine . Costs saving associate algorithm also assess .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . SIRS Criteria SIRS consider present patient one follow clinical finding : body temperature &gt; 38°C &lt; 36°C heart rate &gt; 90 min1 respiratory rate &gt; 20 min1 Paco2 &lt; 32 mm Hg white blood cell count &gt; 12,000 cell µL1 &lt; 4,000 µL1 2. new empiric antibiotic therapy initiate , indicate suspicion infection . Accepted criterion SIRS use Medical Intensive Care Unit Surgical Intensive Care Unit population , appropriate agespecific vital sign definition help make definition relevant Pediatric Intensive Care Unit population . 1. code status `` resuscitate '' 2. absence initiation expansion antibiotic therapy despite meet criterion sepsis 3. presence immunocompromising condition . An immunocompromising condition define one following : human immunodeficiency virus ( HIV ) infection thelper cell ( CD4 ) count &lt; 200 cell/mm3 ; 2 ) immunosuppressive therapy organ transplantation neutropenia ( &lt; 500 neutrophils/mm3 ) active chemotherapy within 3 month precede eligibility diagnosis cystic fibrosis . These criterion represent condition antibiotic use much less likely decreased regardless result biomarker consistent exclusion criterion use past study impact biomarkers .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sepsis , SIRS , antibiotic use , intensive care unit</keyword>
</DOC>